These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 2821862)

  • 1. Gallium nitrate for treatment of refractory hypercalcemia from parathyroid carcinoma.
    Warrell RP; Issacs M; Alcock NW; Bockman RS
    Ann Intern Med; 1987 Nov; 107(5):683-6. PubMed ID: 2821862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gallium nitrate inhibits calcium resorption from bone and is effective treatment for cancer-related hypercalcemia.
    Warrell RP; Bockman RS; Coonley CJ; Isaacs M; Staszewski H
    J Clin Invest; 1984 May; 73(5):1487-90. PubMed ID: 6715548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of hypercalcemia due to parathyroid carcinoma with intravenous dichloromethylene diphosphonate.
    Shane E; Jacobs TP; Siris ES; Steinberg SF; Stoddart K; Canfield RE; Bilezikian JP
    Am J Med; 1982 Jun; 72(6):939-44. PubMed ID: 6211978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gallium nitrate inhibits accelerated bone turnover in patients with bone metastases.
    Warrell RP; Alcock NW; Bockman RS
    J Clin Oncol; 1987 Feb; 5(2):292-8. PubMed ID: 3806170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mithramycin treatment of intractable hypercalcemia due to parathyroid carcinoma.
    Singer FR; Neer RM; Murray TM; Keutmann HT; Deftos LJ; Potts JT
    N Engl J Med; 1970 Sep; 283(12):634-6. PubMed ID: 5450637
    [No Abstract]   [Full Text] [Related]  

  • 6. Calcitonin treatment of hypercalcemia due to parathyroid carcinoma. Synergistic effect of prednisone on long-term treatment of hypercalcemia.
    Au WY
    Arch Intern Med; 1975 Dec; 135(12):1594-7. PubMed ID: 128332
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of cancer-related hypercalcemia: the role of gallium nitrate.
    Leyland-Jones B
    Semin Oncol; 2003 Apr; 30(2 Suppl 5):13-9. PubMed ID: 12776255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of gallium nitrate on tamoxifen induced hypercalcemia in rats bearing mammary tumor.
    Arumugam G; Shanthi P; Sachdanandam P
    Exp Oncol; 2006 Jun; 28(2):141-5. PubMed ID: 16837906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercalcemia induced with the plasma levels of parathyroid hormone-related peptide in multiple myeloma.
    Shionoiri A; Horiuchi T; Onouchi T; Tsutsumi H; Ohta M; Hosoi T; Ito H; Orimo H
    Intern Med; 2000 Oct; 39(10):810-3. PubMed ID: 11030205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First Japanese patient treated with parathyroid hormone peptide immunization for refractory hypercalcemia caused by metastatic parathyroid carcinoma.
    Horie I; Ando T; Inokuchi N; Mihara Y; Miura S; Imaizumi M; Usa T; Kinoshita N; Sekine I; Kamihara S; Eguchi K
    Endocr J; 2010; 57(4):287-92. PubMed ID: 20051648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tumoral hypercalcemia: physiopathology and treatment].
    Rizzoli R; Jung A; Bonjour JP
    Schweiz Med Wochenschr; 1985 Mar; 115(10):326-32. PubMed ID: 3157214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent.
    Collins MT; Skarulis MC; Bilezikian JP; Silverberg SJ; Spiegel AM; Marx SJ
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1083-8. PubMed ID: 9543122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating cancer-related hypercalcemia with gallium nitrate.
    Leyland-Jones B
    J Support Oncol; 2004; 2(6):509-16. PubMed ID: 15605917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of gallium nitrate in nude mice bearing a canine adenocarcinoma (CAC-8) model of humoral hypercalcemia of malignancy.
    Merryman JI; Capen CC; Rosol TJ
    J Bone Miner Res; 1994 May; 9(5):725-32. PubMed ID: 8053402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
    Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of parathyroid secretion after administration of WR-2721 in a patient with parathyroid carcinoma.
    Hirschel-Scholz S; Jung A; Fischer JA; Trechsel U; Bonjour JP
    Clin Endocrinol (Oxf); 1985 Sep; 23(3):313-8. PubMed ID: 3000652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy.
    Rizzoli R; Thiébaud D; Bundred N; Pecherstorfer M; Herrmann Z; Huss HJ; Rückert F; Manegold C; Tubiana-Hulin M; Steinhauer EU; Degardin M; Thürlimann B; Clemens MR; Eghbali H; Body JJ
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3545-50. PubMed ID: 10522993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging role of denosumab in the long-term management of parathyroid carcinoma-related refractory hypercalcemia.
    Fountas A; Andrikoula M; Giotaki Z; Limniati C; Tsakiridou E; Tigas S; Tsatsoulis A
    Endocr Pract; 2015 May; 21(5):468-73. PubMed ID: 25667369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria.
    Pak CY; Oata M; Lawrence EC; Snyder W
    J Clin Invest; 1974 Aug; 54(2):387-400. PubMed ID: 4367891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased prevalence of primary hyperparathyroidism in treated breast cancer.
    Fierabracci P; Pinchera A; Miccoli P; Conte PF; Vignali E; Zaccagnini M; Marcocci C; Giani C
    J Endocrinol Invest; 2001 May; 24(5):315-20. PubMed ID: 11407650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.